Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Chung-Hung Shih, Wen-Hung Wang, Chi-Ming Chen & Wun-Chang Ko. (2020) Hesperetin-5,7,3ʹ-O-Trimethylether Dually Inhibits Phosphodiesterase 3/4 and Methacholine-Induced Airway Hyperresponsiveness in Sensitized and Challenged Mice. Drug Design, Development and Therapy 14, pages 519-526.
Read now
Read now
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Gabriella Matera, Gabriella Pezzuto, Mario Cazzola & Paola Rogliani. (2020) Investigational treatments in phase I and II clinical trials: a systematic review in chronic obstructive pulmonary disease (COPD). Expert Opinion on Investigational Drugs 29:7, pages 723-738.
Read now
Read now
Polyxeni Ntontsi, Aggeliki Detta, Petros Bakakos, Stelios Loukides & Georgios Hillas. (2019) Experimental and investigational phosphodiesterase inhibitors in development for asthma. Expert Opinion on Investigational Drugs 28:3, pages 261-266.
Read now
Read now
Kyung Hoon Kim, Hye Seon Kang, Ju Sang Kim, Hyoung Kyu Yoon, Sung Kyoung Kim & Chin Kook Rhee. (2017) Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 3449-3456.
Read now
Read now
Yanbing Su, Chao Long, Qi Yu, Juan Zhang, Daisy Wu & Zhiguang Duan. (2017) Global scientific collaboration in COPD research. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 215-225.
Read now
Read now
Mario Cazzola, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2016) The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Discovery 11:7, pages 733-744.
Read now
Read now
Ana Martinez & Carmen Gil. (2014) cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases. Expert Opinion on Therapeutic Patents 24:12, pages 1311-1321.
Read now
Read now
Rania O Salama, Paul M Young, Philippe Rogueda, Arthur Lallement, Ilian Iliev & Daniela Traini. (2011) Advances in drug delivery: is triple therapy the future for the treatment of chronic obstructive pulmonary disease?. Expert Opinion on Pharmacotherapy 12:12, pages 1913-1932.
Read now
Read now
Articles from other publishers (5)
Malvika Chawla, R.D. Kaushik, Mayank Kumar Malik, Vishakha Pundir, Jaspal Singh & Hafeezur Rehmaan. (2022) Development and optimization of RofA-PAMAM dendrimer complex materials for sustained drug delivery. Materials Today Communications 33, pages 104881.
Crossref
Crossref
Fabio F. Stellari, Angelo Sala, Francesca Ruscitti, Carola Buccellati, Andrew Allen, Patrizia Risé, Maurizio Civelli & Gino Villetti. (2019) CHF6001 Inhibits NF-κB Activation and Neutrophilic Recruitment in LPS-Induced Lung Inflammation in Mice. Frontiers in Pharmacology 10.
Crossref
Crossref
Laura Carzaniga, Gabriele Amari, Andrea Rizzi, Carmelida Capaldi, Renato De Fanti, Eleonora Ghidini, Gino Villetti, Chiara Carnini, Nadia Moretto, Fabrizio Facchinetti, Paola Caruso, Gessica Marchini, Loredana Battipaglia, Riccardo Patacchini, Valentina Cenacchi, Roberta Volta, Francesco Amadei, Alice Pappani, Silvia Capacchi, Valentina Bagnacani, Maurizio Delcanale, Paola Puccini, Silvia Catinella, Maurizio Civelli & Elisabetta Armani. (2017) Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases. Journal of Medicinal Chemistry 60:24, pages 10026-10046.
Crossref
Crossref
Teresa Röhrig, Olga Pacjuk, Silvia Hernández-Huguet, Johanna Körner, Katharina Scherer & Elke Richling. (2017) Inhibition of Cyclic Adenosine Monophosphate-Specific Phosphodiesterase by Various Food Plant-Derived Phytotherapeutic Agents. Medicines 4:4, pages 80.
Crossref
Crossref
Mariama C. Maiga, Bintou Ahmadou Ahidjo, Mamoudou Maiga & William R. Bishai. (2015) Roflumilast, a Type 4 Phosphodiesterase Inhibitor, Shows Promising Adjunctive, Host-Directed Therapeutic Activity in a Mouse Model of Tuberculosis. Antimicrobial Agents and Chemotherapy 59:12, pages 7888-7890.
Crossref
Crossref